BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25393849)

  • 1. Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model.
    Pandharipande PV; Heberle C; Dowling EC; Kong CY; Tramontano A; Perzan KE; Brugge W; Hur C
    Radiology; 2015 Apr; 275(1):177-87. PubMed ID: 25393849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis.
    Lee JM; Kopans DB; McMahon PM; Halpern EF; Ryan PD; Weinstein MC; Gazelle GS
    Radiology; 2008 Mar; 246(3):763-71. PubMed ID: 18309013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing to guide screening for pancreatic ductal adenocarcinoma: Results of a microsimulation model.
    Peters MLB; Eckel A; Lietz A; Seguin C; Mueller P; Hur C; Pandharipande PV
    Pancreatology; 2022 Sep; 22(6):760-769. PubMed ID: 35752568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Pancreatic Adenocarcinoma in BRCA2 Mutation Carriers: Results of a Disease Simulation Model.
    Pandharipande PV; Jeon A; Heberle CR; Dowling EC; Kong CY; Chung DC; Brugge WR; Hur C
    EBioMedicine; 2015 Dec; 2(12):1980-6. PubMed ID: 26844277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: Results of a simulation model.
    Peters MLB; Eckel A; Mueller PP; Tramontano AC; Weaver DT; Lietz A; Hur C; Kong CY; Pandharipande PV
    Pancreatology; 2018 Dec; 18(8):928-934. PubMed ID: 30143405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
    Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
    J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
    Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
    Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of Abdominal Ultrasound Versus Magnetic Resonance Imaging for Pancreatic Cancer Screening in Familial High-Risk Individuals in Japan.
    Kowada A
    Pancreas; 2020 Sep; 49(8):1052-1056. PubMed ID: 32769852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
    Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
    Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging Follow-up of Low-Risk Incidental Pancreas and Kidney Findings: Effects of Patient Age and Comorbidity on Projected Life Expectancy.
    Raphel TJ; Weaver DT; Berland LL; Herts BR; Megibow AJ; Knudsen AB; Pandharipande PV
    Radiology; 2018 May; 287(2):504-514. PubMed ID: 29401040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
    Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
    Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projected Effects of Radiation-Induced Cancers on Life Expectancy in Patients Undergoing CT Surveillance for Limited-Stage Hodgkin Lymphoma: A Markov Model.
    Lowry KP; Turan EA; Eisenberg J; Kong CY; Barnes JA; Pandharipande PV
    AJR Am J Roentgenol; 2015 Jun; 204(6):1228-33. PubMed ID: 26001232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model.
    Mühlberger N; Boskovic K; Krahn MD; Bremner KE; Oberaigner W; Klocker H; Horninger W; Sroczynski G; Siebert U
    BMC Public Health; 2017 Jun; 17(1):596. PubMed ID: 28651567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsimulation model of CT versus MRI surveillance of Bosniak IIF renal cystic lesions: should effects of radiation exposure affect selection of imaging strategy?
    Kang SK; Turan EA; Eisenberg JD; Lee PA; Kong CY; Pandharipande PV
    AJR Am J Roentgenol; 2014 Dec; 203(6):W629-36. PubMed ID: 25415728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
    Kerlikowske K; Salzmann P; Phillips KA; Cauley JA; Cummings SR
    JAMA; 1999 Dec; 282(22):2156-63. PubMed ID: 10591338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.
    Del Chiaro M; Verbeke CS; Kartalis N; Pozzi Mucelli R; Gustafsson P; Hansson J; Haas SL; Segersvärd R; Andren-Sandberg Å; Löhr JM
    JAMA Surg; 2015 Jun; 150(6):512-8. PubMed ID: 25853369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Pancreatic Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Henrikson NB; Aiello Bowles EJ; Blasi PR; Morrison CC; Nguyen M; Pillarisetty VG; Lin JS
    JAMA; 2019 Aug; 322(5):445-454. PubMed ID: 31386140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
    Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
    Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of breast cancer screening in women on dialysis.
    Wong G; Howard K; Chapman JR; Craig JC
    Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.